In the present study, we assessed whether I3 exhibited an inhibitory activity by inducing cell differentiation against AML cells with t (8; 21) translocation or MLLr and leukemic stem-like cells (Kasumi-1, MOLM-13, THP-1, and KG-1). The gene discussed is BRI3; the disease is acute myeloid leukemia.